• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jmedgeneJournal of Medical GeneticsCurrent TOCInstructions for authors
J Med Genet. Jan 2004; 41(1): 1–5.
PMCID: PMC1757264

BRCA1 functions as a breast stem cell regulator

Full Text

The Full Text of this article is available as a PDF (169K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lajtha LG. Stem cell concepts. Differentiation. 1979;14(1-2):23–34. [PubMed]
  • Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994 Jan;70(1):6–22. [PubMed]
  • Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001 Nov 1;414(6859):105–111. [PubMed]
  • Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature. 2000 Aug 17;406(6797):747–752. [PubMed]
  • van 't Veer Laura J, Dai Hongyue, van de Vijver Marc J, He Yudong D, Hart Augustinus A M, Mao Mao, Peterse Hans L, van der Kooy Karin, Marton Matthew J, Witteveen Anke T, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002 Jan 31;415(6871):530–536. [PubMed]
  • Ramaswamy Sridhar, Ross Ken N, Lander Eric S, Golub Todd R. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003 Jan;33(1):49–54. [PubMed]
  • Al-Hajj Muhammad, Wicha Max S, Benito-Hernandez Adalberto, Morrison Sean J, Clarke Michael F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983–3988. [PMC free article] [PubMed]
  • Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. [PubMed]
  • Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985 Mar;52(3):243–256. [PubMed]
  • Lakhani SR, O'Hare MJ. The mammary myoepithelial cell--Cinderella or ugly sister? Breast Cancer Res. 2001;3(1):1–4. [PMC free article] [PubMed]
  • Dulbecco R, Allen WR, Bologna M, Bowman M. Marker evolution during the development of the rat mammary gland: stem cells identified by markers and the role of myoepithelial cells. Cancer Res. 1986 May;46(5):2449–2456. [PubMed]
  • Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst. 1998 Aug 5;90(15):1138–1145. [PubMed]
  • Chappuis PO, Nethercot V, Foulkes WD. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. Semin Surg Oncol. 2000 Jun;18(4):287–295. [PubMed]
  • Russo J, Lynch H, Russo IH. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J. 2001 Sep-Oct;7(5):278–291. [PubMed]
  • Venkitaraman Ashok R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002 Jan 25;108(2):171–182. [PubMed]
  • Korhonen L, Brännvall K, Skoglösa Y, Lindholm D. Tumor suppressor gene BRCA-1 is expressed by embryonic and adult neural stem cells and involved in cell proliferation. J Neurosci Res. 2003 Mar 15;71(6):769–776. [PubMed]
  • Smith GH, Chepko G. Mammary epithelial stem cells. Microsc Res Tech. 2001 Jan 15;52(2):190–203. [PubMed]
  • Rudland PS. Epithelial stem cells and their possible role in the development of the normal and diseased human breast. Histol Histopathol. 1993 Apr;8(2):385–404. [PubMed]
  • Gudjonsson Thorarinn, Villadsen René, Nielsen Helga Lind, Rønnov-Jessen Lone, Bissell Mina J, Petersen Ole William. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002 Mar 15;16(6):693–706. [PMC free article] [PubMed]
  • Bartek J, Taylor-Papadimitriou J, Miller N, Millis R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours. Int J Cancer. 1985 Sep 15;36(3):299–306. [PubMed]
  • Böcker Werner, Moll Roland, Poremba Christopher, Holland Roland, Van Diest Paul J, Dervan Peter, Bürger Horst, Wai Daniel, Ina Diallo Raihanatou, Brandt Burkhard, et al. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest. 2002 Jun;82(6):737–746. [PubMed]
  • Böcker W, Bier B, Freytag G, Brömmelkamp B, Jarasch ED, Edel G, Dockhorn-Dworniczak B, Schmid KW. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Arch A Pathol Anat Histopathol. 1992;421(4):323–330. [PubMed]
  • Daniel DC. Dual immunofluorescence labeling with cell-specific markers localizes BRCA1 in both basal and luminal epithelial cells in primary outgrowth from noncancerous mammary ductal and alveolar preparations. Cell Tissue Res. 1999 Dec;298(3):481–487. [PubMed]
  • Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 1996 Jun 28;85(7):1009–1023. [PubMed]
  • Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003 May;72(5):1117–1130. [PMC free article] [PubMed]
  • Owens David M, Watt Fiona M. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer. 2003 Jun;3(6):444–451. [PubMed]
  • Zeps N, Bentel JM, Papadimitriou JM, D'Antuono MF, Dawkins HJ. Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth. Differentiation. 1998 Mar;62(5):221–226. [PubMed]
  • Clarke RB, Howell A, Potten CS, Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 1997 Nov 15;57(22):4987–4991. [PubMed]
  • Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet JS, Narod SA, Slingerland J, Foulkes WD. Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer. J Clin Oncol. 2000 Dec 15;18(24):4045–4052. [PubMed]
  • Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001 Feb 22;344(8):539–548. [PubMed]
  • Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res. 2001 May 15;61(10):4092–4097. [PubMed]
  • Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869–10874. [PMC free article] [PubMed]
  • van de Rijn Matt, Perou Charles M, Tibshirani Rob, Haas Phillippe, Kallioniemi Olli, Kononen Juha, Torhorst Joachim, Sauter Guido, Zuber Markus, Köchli Ossi R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002 Dec;161(6):1991–1996. [PMC free article] [PubMed]
  • Foulkes William D, Stefansson Ingunn M, Chappuis Pierre O, Bégin Louis R, Goffin John R, Wong Nora, Trudel Michel, Akslen Lars A. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003 Oct 1;95(19):1482–1485. [PubMed]
  • Sorlie Therese, Tibshirani Robert, Parker Joel, Hastie Trevor, Marron JS, Nobel Andrew, Deng Shibing, Johnsen Hilde, Pesich Robert, Geisler Stephanie, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418–8423. [PMC free article] [PubMed]
  • Korsching Eberhard, Packeisen Jens, Agelopoulos Konstantin, Eisenacher Martin, Voss Reinhard, Isola Jorma, van Diest Paul J, Brandt Burkhard, Boecker Werner, Buerger Horst. Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest. 2002 Nov;82(11):1525–1533. [PubMed]
  • Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, van Geel AA, Menke M, Verhoog LC, van den Ouweland A, et al. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol. 2001 Feb 15;19(4):924–930. [PubMed]
  • Foulkes William D, Metcalfe Kelly, Hanna Wedad, Lynch Henry T, Ghadirian Parviz, Tung Nadine, Olopade Olofunmilayo, Weber Barbara, McLennan Jane, Olivotto Ivo A, et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 2003 Oct 15;98(8):1569–1577. [PubMed]
  • Bernards René, Weinberg Robert A. A progression puzzle. Nature. 2002 Aug 22;418(6900):823–823. [PubMed]
  • Eerola H, Vahteristo P, Sarantaus L, Kyyrönen P, Pyrhönen S, Blomqvist C, Pukkala E, Nevanlinna H, Sankila R. Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer. 2001 Aug 1;93(3):368–372. [PubMed]
  • Møller Pål, Borg Ake, Evans D Gareth, Haites Neva, Reis Marta M, Vasen Hans, Anderson Elaine, Steel C Michael, Apold Jaran, Goudie David, et al. Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer. 2002 Oct 20;101(6):555–559. [PubMed]
  • Goffin John R, Chappuis Pierre O, Bégin Louis R, Wong Nora, Brunet Jean-Sébastien, Hamel Nancy, Paradis Ann-Josée, Boyd Jeff, Foulkes William D. Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data. Cancer. 2003 Feb 1;97(3):527–536. [PubMed]
  • Foulkes WD, Rosenblatt J, Chappuis PO. The contribution of inherited factors to the clinicopathological features and behavior of breast cancer. J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):453–465. [PubMed]
  • Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997 Feb;3(2):222–225. [PubMed]
  • Signoretti Sabina, Di Marcotullio Lucia, Richardson Andrea, Ramaswamy Sridhar, Isaac Beth, Rue Montserrat, Monti Franco, Loda Massimo, Pagano Michele. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest. 2002 Sep;110(5):633–641. [PMC free article] [PubMed]
  • Catteau A, Harris WH, Xu CF, Solomon E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999 Mar 18;18(11):1957–1965. [PubMed]
  • Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst. 2000 Apr 5;92(7):564–569. [PubMed]
  • Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, et al. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. Lancet. 1999 Nov 27;354(9193):1846–1850. [PubMed]
  • Lambe M, Hsieh C, Trichopoulos D, Ekbom A, Pavia M, Adami HO. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 1994 Jul 7;331(1):5–9. [PubMed]
  • Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 1999 May;22(1):37–43. [PubMed]
  • Buchholz Thomas A, Wu Xifeng, Hussain Abu, Tucker Susan L, Mills Gordon B, Haffty Bruce, Bergh Sherry, Story Michael, Geara Fady B, Brock William A. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int J Cancer. 2002 Feb 10;97(5):557–561. [PubMed]
  • Kordon EC, Smith GH. An entire functional mammary gland may comprise the progeny from a single cell. Development. 1998 May;125(10):1921–1930. [PubMed]
  • Medina Daniel, Kittrell Frances S, Shepard Anne, Stephens L Clifton, Jiang Cheng, Lu Junxuan, Allred D Craig, McCarthy Maureen, Ullrich Robert L. Biological and genetic properties of the p53 null preneoplastic mammary epithelium. FASEB J. 2002 Jun;16(8):881–883. [PubMed]
  • Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet. 2001 Jul;28(3):266–271. [PubMed]
  • Cao Liu, Li Wenmei, Kim Sangsoo, Brodie Steven G, Deng Chu-Xia. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev. 2003 Jan 15;17(2):201–213. [PMC free article] [PubMed]
  • Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, Hall PA. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 1994 Feb 1;54(3):614–617. [PubMed]
  • Hartman Anne-Renee, Ford James M. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet. 2002 Sep;32(1):180–184. [PubMed]
  • Chepko G, Dickson RB. Ultrastructure of the putative stem cell niche in rat mammary epithelium. Tissue Cell. 2003 Apr;35(2):83–93. [PubMed]
  • Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000 Nov 23;408(6811):429–432. [PMC free article] [PubMed]
  • Haber D. Roads leading to breast cancer. N Engl J Med. 2000 Nov 23;343(21):1566–1568. [PubMed]
  • Narod S. Roads to breast cancer. N Engl J Med. 2001 Mar 22;344(12):937–937. [PubMed]
  • van Slooten HJ, van de Vijver MJ, van de Velde CJ, van Dierendonck JH. Loss of Bcl-2 in invasive breast cancer is associated with high rates of cell death, but also with increased proliferative activity. Br J Cancer. 1998 Mar;77(5):789–796. [PMC free article] [PubMed]
  • Buchholz Thomas A, Davis Darren W, McConkey David J, Symmans W Fraser, Valero Vicente, Jhingran Anuja, Tucker Susan L, Pusztai Lajos, Cristofanilli Massimo, Esteva Francisco J, et al. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J. 2003 Jan-Feb;9(1):33–41. [PubMed]
  • Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X. Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer. 2000 Nov;83(10):1318–1322. [PMC free article] [PubMed]
  • Chappuis PO, Goffin J, Wong N, Perret C, Ghadirian P, Tonin PN, Foulkes WD. A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet. 2002 Aug;39(8):608–610. [PMC free article] [PubMed]
  • Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA. 2000 May 3;283(17):2260–2265. [PubMed]
  • Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001 Sep;7(9):1028–1034. [PubMed]
  • Sun CC, Lenoir G, Lynch H, Narod SA. In-situ breast cancer and BRCA1. Lancet. 1996 Aug 10;348(9024):408–408. [PubMed]
  • Kauff Noah D, Brogi Edi, Scheuer Lauren, Pathak Dorothy R, Borgen Patrick I, Hudis Clifford A, Offit Kenneth, Robson Mark E. Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations. Cancer. 2003 Apr 1;97(7):1601–1608. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...